Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 8 | 2023 | 110 | 2.430 |
Why?
|
| Bone Regeneration | 4 | 2023 | 74 | 2.280 |
Why?
|
| Bone and Bones | 6 | 2024 | 118 | 1.520 |
Why?
|
| Bone Marrow | 3 | 2023 | 79 | 1.440 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 33 | 1.420 |
Why?
|
| Animals | 27 | 2024 | 3780 | 1.400 |
Why?
|
| Mice | 18 | 2023 | 1461 | 1.370 |
Why?
|
| Phosphates | 3 | 2021 | 22 | 1.330 |
Why?
|
| Fractures, Bone | 2 | 2020 | 75 | 1.200 |
Why?
|
| Implants, Experimental | 3 | 2021 | 32 | 0.940 |
Why?
|
| Osteoblasts | 3 | 2021 | 55 | 0.850 |
Why?
|
| Endothelial Cells | 1 | 2023 | 61 | 0.840 |
Why?
|
| Circadian Clocks | 1 | 2022 | 32 | 0.800 |
Why?
|
| Bone Development | 2 | 2020 | 32 | 0.730 |
Why?
|
| Models, Genetic | 1 | 2020 | 42 | 0.700 |
Why?
|
| Adipose Tissue | 2 | 2021 | 78 | 0.690 |
Why?
|
| Bone Resorption | 2 | 2017 | 85 | 0.650 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 23 | 0.580 |
Why?
|
| Diphosphonates | 1 | 2017 | 17 | 0.540 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 619 | 0.480 |
Why?
|
| Tibia | 2 | 2017 | 244 | 0.480 |
Why?
|
| Cartilage, Articular | 2 | 2017 | 420 | 0.480 |
Why?
|
| Osteoarthritis, Knee | 2 | 2017 | 366 | 0.470 |
Why?
|
| Cell Differentiation | 3 | 2021 | 135 | 0.470 |
Why?
|
| Osteoarthritis | 2 | 2023 | 328 | 0.460 |
Why?
|
| Weight-Bearing | 5 | 2018 | 159 | 0.460 |
Why?
|
| Biomechanical Phenomena | 6 | 2020 | 645 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 435 | 0.430 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 48 | 0.410 |
Why?
|
| Cartilage | 1 | 2013 | 102 | 0.400 |
Why?
|
| Femur | 4 | 2021 | 382 | 0.390 |
Why?
|
| Male | 12 | 2022 | 15291 | 0.350 |
Why?
|
| Bone Density | 5 | 2022 | 143 | 0.340 |
Why?
|
| Osseointegration | 2 | 2021 | 67 | 0.340 |
Why?
|
| Cancellous Bone | 2 | 2021 | 5 | 0.330 |
Why?
|
| X-Ray Microtomography | 5 | 2021 | 82 | 0.310 |
Why?
|
| Mice, Knockout | 4 | 2022 | 316 | 0.300 |
Why?
|
| Female | 11 | 2024 | 15730 | 0.250 |
Why?
|
| Stress, Mechanical | 2 | 2018 | 162 | 0.250 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 53 | 0.230 |
Why?
|
| Premature Birth | 1 | 2024 | 11 | 0.230 |
Why?
|
| Rats | 3 | 2021 | 678 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 59 | 0.220 |
Why?
|
| Alkaline Phosphatase | 2 | 2024 | 19 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 15 | 0.210 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 10 | 0.210 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2023 | 9 | 0.210 |
Why?
|
| Osteoporosis | 2 | 2021 | 76 | 0.210 |
Why?
|
| Colitis | 1 | 2023 | 37 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 341 | 0.200 |
Why?
|
| Epithelial Cells | 1 | 2022 | 84 | 0.200 |
Why?
|
| RNA | 1 | 2021 | 37 | 0.190 |
Why?
|
| Cortical Bone | 1 | 2021 | 7 | 0.190 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2021 | 4 | 0.190 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 10 | 0.190 |
Why?
|
| Palatal Expansion Technique | 1 | 2021 | 2 | 0.190 |
Why?
|
| Orthodontic Anchorage Procedures | 1 | 2021 | 2 | 0.190 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 283 | 0.190 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 51 | 0.180 |
Why?
|
| Bone Remodeling | 2 | 2018 | 49 | 0.180 |
Why?
|
| Humans | 12 | 2024 | 28436 | 0.180 |
Why?
|
| Synovial Membrane | 2 | 2023 | 51 | 0.180 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.180 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 7 | 0.180 |
Why?
|
| Gene Expression | 1 | 2021 | 202 | 0.180 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 18 | 0.170 |
Why?
|
| Osteophyte | 2 | 2017 | 7 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 30 | 0.170 |
Why?
|
| Surface Properties | 1 | 2019 | 140 | 0.160 |
Why?
|
| Joint Prosthesis | 1 | 2020 | 89 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2020 | 118 | 0.160 |
Why?
|
| Glycoproteins | 1 | 2019 | 46 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 55 | 0.160 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 299 | 0.160 |
Why?
|
| Duodenum | 1 | 2018 | 6 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 9 | 0.150 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 19 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2020 | 447 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 2021 | 25 | 0.150 |
Why?
|
| Disease Progression | 2 | 2018 | 717 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 225 | 0.140 |
Why?
|
| Adipocytes | 1 | 2016 | 21 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 192 | 0.130 |
Why?
|
| Body Composition | 1 | 2016 | 69 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2016 | 69 | 0.130 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2016 | 87 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 397 | 0.120 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2016 | 196 | 0.110 |
Why?
|
| Caveolin 1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 27 | 0.090 |
Why?
|
| Knee Joint | 1 | 2016 | 746 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 105 | 0.090 |
Why?
|
| Weightlessness | 2 | 2021 | 3 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 730 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2024 | 45 | 0.060 |
Why?
|
| Swine | 1 | 2024 | 81 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 10 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2024 | 219 | 0.050 |
Why?
|
| Feces | 1 | 2023 | 113 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 654 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 192 | 0.050 |
Why?
|
| Hindlimb Suspension | 1 | 2021 | 2 | 0.050 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 6 | 0.050 |
Why?
|
| Colon | 1 | 2023 | 142 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 43 | 0.050 |
Why?
|
| Rats, Zucker | 1 | 2021 | 7 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2021 | 26 | 0.050 |
Why?
|
| Palate | 1 | 2021 | 4 | 0.050 |
Why?
|
| Phenotype | 1 | 2022 | 313 | 0.050 |
Why?
|
| Cattle | 1 | 2021 | 127 | 0.050 |
Why?
|
| Titanium | 1 | 2021 | 181 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2020 | 20 | 0.040 |
Why?
|
| Bone Screws | 1 | 2021 | 146 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 161 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 65 | 0.040 |
Why?
|
| Arthroplasty, Replacement | 1 | 2020 | 153 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 1 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 28 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 36 | 0.040 |
Why?
|
| Gravity, Altered | 1 | 2018 | 1 | 0.040 |
Why?
|
| Moon | 1 | 2018 | 2 | 0.040 |
Why?
|
| Centrifugation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Space Flight | 1 | 2018 | 6 | 0.040 |
Why?
|
| Models, Animal | 1 | 2018 | 115 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 52 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2018 | 56 | 0.040 |
Why?
|
| Alendronate | 1 | 2017 | 7 | 0.040 |
Why?
|
| Epiphyses | 1 | 2017 | 10 | 0.040 |
Why?
|
| Macrophages | 1 | 2018 | 108 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 14 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2018 | 308 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2018 | 539 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 1491 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 536 | 0.030 |
Why?
|
| Radiostereometric Analysis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 181 | 0.030 |
Why?
|
| Hong Kong | 1 | 2012 | 2 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 13 | 0.020 |
Why?
|
| Clone Cells | 1 | 2012 | 12 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 24 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 25 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 45 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 185 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 106 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 269 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 82 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 178 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 249 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 177 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 356 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 160 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 2307 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 2069 | 0.020 |
Why?
|
| Adult | 1 | 2012 | 8107 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 9269 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 9277 | 0.010 |
Why?
|